Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Oct 17:12:229.
doi: 10.1186/1745-6215-12-229.

Which dressing do donor site wounds need?: study protocol for a randomized controlled trial

Anne M Eskes  1 , Fleur E Brölmann, Louise A A Gerbens, Dirk T Ubbink, Hester Vermeulen; REMBRANDT study group
Collaborators, Affiliations
Randomized Controlled Trial

Which dressing do donor site wounds need?: study protocol for a randomized controlled trial

Anne M Eskes et al. Trials. .

Abstract

Background: Donor site wounds after split-skin grafting are rather 'standard' wounds. At present, lots of dressings and topical agents for donor site wounds are commercially available. This causes large variation in the local care of these wounds, while the optimum 'standard' dressing for local wound care is unclear. This protocol describes a trial in which we investigate the effectiveness of various treatment options for these donor site wounds.

Methods: A 14-center, six-armed randomized clinical trial is being carried out in the Netherlands. An a-priori power analysis and an anticipated dropout rate of 15% indicates that 50 patients per group are necessary, totaling 300 patients, to be able to detect a 25% quicker mean time to complete wound healing. Randomization has been computerized to ensure allocation concealment. Adult patients who need a split-skin grafting operation for any reason, leaving a donor site wound of at least 10 cm2 are included and receive one of the following dressings: hydrocolloid, alginate, film, hydrofiber, silicone dressing, or paraffin gauze. No combinations of products from other intervention groups in this trial are allowed. Optimum application and changes of these dressings are pursued according to the protocol as supplied by the dressing manufacturers. Primary outcomes are days to complete wound healing and pain (using a Visual Analogue Scale). Secondary outcomes are adverse effects, scarring, patient satisfaction, and costs. Outcome assessors unaware of the treatment allocation will assess whether or not an outcome has occurred. Results will be analyzed according to the intention to treat principle. The first patient was randomized October 1, 2009.

Discussion: This study will provide comprehensive data on the effectiveness of different treatment options for donor site wounds. The dressing(s) that will prevail in effectiveness, satisfaction and costs will be promoted among clinicians dealing with such patients. Thus, we aim to contribute a well-designed trial, relevant to all clinicians involved in the care for donor site wounds, which will help enhance uniformity and quality of care for these patients.

Trial registration: http://www.trialregister.nl, NTR1849. Date registered: June 9, 2009.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the Rembrandt Trial.
See this image and copyright information in PMC

References

    1. Rakel BA, Bermel MA, Abbott LI, Baumler SK, Burger MR, Dawson CJ, Heinle JA, Ocheltree IM. Split-thickness skin graft donor site care: a quantitative synthesis of the research. Appl Nurs Res. 1998;11(4):174–182. doi: 10.1016/S0897-1897(98)80296-6. - DOI - PubMed
    1. Wiechula R. The use of moist wound-healing dressings in the management of split-thickness skin graft donor sites: a systematic review. Int J Nurs Pract. 2003;9(2):S9–17. doi: 10.1046/j.1322-7114.2003.00417.x. - DOI - PubMed
    1. Ratner D. Skin grafting. Semin Cutan Med Surg. 2003;22(4):295–305. doi: 10.1016/S1085-5629(03)00079-8. - DOI - PubMed
    1. Persson K, Salemark L. How to dress donor sites of split thickness skin grafts: a prospective, randomised study of four dressings. Scand J Plast Reconstr Surg Hand Surg. 2000;34(1):55–59. doi: 10.1080/02844310050160178. - DOI - PubMed
    1. Feldman DL. Which dressing for split-thickness skin graft donor sites? Ann Plast Surg. 1991;27(3):288–291. doi: 10.1097/00000637-199109000-00017. - DOI - PubMed

Publication types